The purpose of this review is to provide a succinct description of the recent findings that advance our understanding of the fundamental renal process of ammonia metabolism and transport in conditions relevant to the clinician.
INTRODUCTION
Normal acid-base balance is critical for normal health, and failure to achieve this leads to a wide variety of clinical disorders, including growth retardation, nausea and vomiting, electrolyte disturbances, cardiac arrhythmias, impaired cardiovascular catecholamine sensitivity, osteoporosis and osteomalacia, nephrolithiasis, skeletal muscle atrophy, and accelerated progression of chronic kidney disease (CKD) [1 & ,2]. Recent studies also show an important correlation between abnormal acid-base homeostasis and increased mortality [3 && ]. The kidneys contribute to acid-base homeostasis by net acid excretion, which is achieved by ammonia (ammonia exists in two molecular forms, NH 3 and NH 4 þ , that are in equilibrium with each other. We use the term 'ammonia' to refer to the combination of these two molecular forms. When referring to a specific molecular form, we state specifically either 'NH 3 
OVERVIEW OF RENAL AMMONIA METABOLISM
Renal ammonia metabolism differs fundamentally from the excretion of most other urinary solutes. Most urinary solutes are delivered to the kidneys via the renal artery and then are excreted in the urine through a combination of glomerular filtration and renal tubular transport. In contrast, less than 5% of urinary ammonia derives from arterial delivery. Instead, kidneys produce ammonia in a metabolic process that results in equimolar bicarbonate generation. Under basal conditions, $50% of the ammonia that is produced is excreted in urine and 50% is added to the systemic circulation via renal veins. Changes in urinary ammonia excretion can result either from changes in net ammonia generation or from changes in renal epithelial cell ammonia transport that determines the proportion that is excreted in the urine versus that delivered to the systemic circulation.
CHRONIC KIDNEY DISEASE AND AMMONIA METABOLISM
CKD is a common cause of abnormal acid-base homeostasis. In addition to its many other adverse effects, CKD is an important risk factor for the development of metabolic acidosis [5] , if not explicitly a cause of it. As Fig. 1 shows, $40% of individuals with advanced CKD develop metabolic acidosis. The metabolic acidosis primarily results from decreased ammonia excretion. Importantly, both animal and human studies show that acidosis worsens the progression of CKD and that correcting the acidosis slows the progression [6] [7] [8] [9] . Thus, a positive feedback cycle can develop, in which CKD causes metabolic acidosis, which leads to worsening of the CKD, leading to worsened metabolic acidosis, and to other related concerns.
Altered ammonia metabolism likely contributes to the acidosis seen in patients with CKD. A recent study examined the effect of CKD on renal ammonia metabolism in a rat model and showed that the decreased ammonia excretion seen in advanced CKD was associated with impaired expression of multiple proteins involved in renal ammonia metabolism, including the glutamine transporter, SN1, the ammoniagenic enzymes, PDG and PEPCK, and the ammonia transporter, Rhcg [10 && ]. Another, slightly older study, using a less severe model of CKD, found that normal acid-base homeostasis in normal urinary ammonia excretion could be achieved through increased single nephron ammonia excretion [11] , consistent with earlier studies [12] , and that the increased single nephron ammonia excretion was associated with increased apical and basolateral polarization of Rhcg without changes in total expression [11] .
Whether ammonia itself directly contributes to the progression of CKD has been an intriguing question for many years. A classic study [6] , one of the early studies to show that metabolic acidosis contributed to CKD progression, suggested that ammonia itself, possibly by activating complement, accelerated the progression of renal injury. Although in-vitro studies suggest that ammonia can activate complement directly, it is possible that reversible binding of interstitial ammonia by sulfatides [13] may limit unbound interstitial ammonia concentrations and thereby minimize this effect. Consistent with this conclusion, a recent clinical study showed, after controlling for the degree of metabolic acidosis, that low urinary ammonia excretion, not high ammonia, correlated with an
KEY POINTS
In a model of CKD, multiple components of renal ammonia metabolism, the primary component of net acid excretion, were inhibited, thereby contributing to the development of metabolic acidosis.
Changes in dietary protein intake, both increase and decrease, induce a coordinated response of multiple components of renal ammonia metabolism that results in maintenance of nitrogen balance and acidbase homeostasis.
Chronic lithium intake results in a substantial stimulation of renal ammonia excretion and metabolism.
Cell-specific gene deletion shows that ammonia recycling via glutamine synthetase expression in the proximal tubule is necessary for normal basal and acidosis-stimulated renal ammonia metabolism.
The proximal tubule basolateral bicarbonate transporter, NBCe1, has a critical role in renal ammonia and organic anion metabolism.
The ammonia transporter family member, Rhbg, appears to transport both NH 3 increased risk of worsening of renal function [14 && ]. Thus, maintenance of adequate renal ammonia metabolism may be protective for patients with CKD.
DIETARY PROTEIN AND AMMONIA METABOLISM
Decreased dietary protein intake has multiple benefits for patients with CKD. In addition, protein intake is a major determinant of endogenous acid production, and thus it is necessary that urinary ammonia excretion change in parallel with protein intake. A recent study [15 & ] has addressed the effect of dietary protein on ammonia metabolism in detail. Dietary protein restriction decreased urinary ammonia excretion by approximately 85% within 2 days. Expression of phosphate-dependent glutaminase (PDG) and phosphoenolpyruvate carboxykinase (PEPCK), key proteins involved in ammonia generation, decreased, whereas expression of the ammonia recycling protein, glutamine synthetase, increased [15 & ]. Importantly, none of the individual changes could account quantitatively for the degree of decreased ammonia excretion; it was the coordinated effect that appeared to be necessary. Also, decreased glutamine synthetase expression could have an important role in nitrogen conservation in response to dietary protein restriction. Thus, dietary protein restriction induces coordinated expression consistent with decreasing urinary ammonia excretion.
Another, slightly older, study examined the converse condition, the response to high dietary protein intake, and showed that it was the metabolism to generate fixed acids, not the nitrogen content, that was responsible for the increased ammonia excretion. Second, it demonstrated increased expression of two key proteins involved in ammonia generation, glutamine transporter, SN1, and PDG [16] . Rhcg mRNA expression increased, and Rhcg gene deletion showed that Rhcg expression was necessary for the initial increase in ammonia excretion [16] . Rhcg's role in the response to high protein diet contrasted with a lack of necessity for Rhcg in the response to dietary protein restriction [15 & ].
The two studies, when taken together, indicate that changes in dietary protein induce coordinated changes in many aspects of renal ammonia metabolism. Whether the minor differences in the responses involved in adaptation to low versus high protein diet reflect fundamental differences or minor variations associated with slightly different models and mice cannot be differentiated at this time.
An unexpected finding in the studies of dietary protein restriction is related to the ammonia transporter family member, Rhbg. Dietary protein restriction, even though it decreased ammonia excretion, increased Rhbg expression in intercalated cells in the inner stripe of the outer medullary collecting duct [15 & ]. In general, Rhbg expression parallels changes in ammonia excretion, and thus the observation of increased Rhbg expression in a state of decreased ammonia excretion was not predicted. Increased Rhbg expression, however, did not appear necessary for the increase in ammonia excretion, as collecting duct-specific Rhbg deletion did not alter the response to dietary protein restriction [15 & ]. This observation suggests that Rhbg has an yet unidentified biological role in addition to its contribution to transepithelial ammonia transport.
LITHIUM AND AMMONIA EXCRETION
Chronic lithium administration is another common clinical condition for which new information regarding ammonia metabolism is available. Acute lithium administration is well known to increase urine pH. Urine pH, however, does not necessarily correlate with net acid or ammonia excretion. A recent study [17 & ], examining people treated chronically with lithium, showed increased basal rates of urinary ammonia excretion and an intact, if not increased, ability to increase ammonia excretion following acid loading (Fig. 2) . Identical findings were observed in an animal model, and this increased ammonia excretion correlated with increased expression of the ammonia transporter, Rhcg [17 & ]. Ammonia excretion requires parallel H þ and NH 3 secretion in the collecting duct, and chronic lithium administration is known to increase the number of acid-secreting intercalated cells and the expression of H þ -ATPase [18, 19] . Thus, not only does chronic lithium therapy not routinely induce distal renal tubular acidosis (RTA), but is also actually associated with enhanced renal net acid excretion. The findings also emphasize the importance of not assuming that changes in urine pH predict changes in net acid excretion.
METABOLIC PROCESSES INVOLVED IN 'NET' AMMONIA GENERATION
The kidney is a net producer of ammonia, and this results from metabolism of amino acids, predominantly glutamine, that results in equimolar NH 4 þ and HCO 3 À generation. There also is a complementary mechanism through which kidneys 'recycle' NH 4 þ and 'regenerate' glutamine. The process involves the enzyme, glutamine synthetase, which catalyzes the reaction as follows:
Several previous studies have shown that glutamine synthetase expression is negatively correlated with ammonia excretion, that is, conditions that increase ammonia excretion decrease glutamine synthetase expression, and vice versa [15 & ,20-24] . A recent study substantially advances our understanding of glutamine synthetase's role in renal ammonia excretion. As previous studies have shown that glutamine synthetase is expressed in cells involved in ammonia production, that is, proximal tubule cells, and cells involved in transepithelial ammonia transport, that is, distal convoluted tubule and intercalated cells, and that glutamine synthetase expression can be differentially regulated in these different cell populations [20] , the authors of this recent study used cell-specific glutamine synthetase deletion to determine the specific role of proximal tubule glutamine synthetase in renal ammonia metabolism. Proximal tubulespecific deletion increased basal ammonia excretion (Fig. 3) , consistent with decreased ammonia recycling leading to increased net ammonia generation and excretion [25 & ]. There also was an impaired ability to respond to an acid load [25 & ], indicating that the ability to alter glutamine synthetase-mediated ammonia recycling is critical to increasing net ammoniagenesis. The findings demonstrate the presence of a 'yin-yang' mechanism regulating 'net' ammoniagenesis, one involving ammonia generation and another involving ammonia recycling. The two mechanisms likely act in concert in order to optimize renal ammonia generation.
REGULATION OF AMMONIA GENERATION
The recent finding that expression of the proximal tubule basolateral bicarbonate transporter, NBCe1, is necessary for normal renal ammonia metabolism is an important advance in understanding the mechanisms regulating ammonia generation. Proximal tubule NBCe1 mediates coupled cotransport of Na þ with three HCO 3 À equivalents, and is the primary mechanism of proximal tubule basolateral bicarbonate exit, and genetic abnormalities in it are the major genetic cause of proximal RTA [26] . NBCe1 deletion causes metabolic acidosis [27,28 & ], which should increase ammonia excretion, yet recent studies show that NBCe1 deletion decreased ammonia excretion ( Fig. 4) [28 & ]. This occurred despite intact urine acidification and intact expression of the collecting duct ammonia transport proteins, Rhbg and Rhcg [28 & ]. Decreased ammonia excretion appeared to result from abnormal expression of multiple enzymes involved in ammonia metabolism. There was decreased expression of the major proximal tubule enzymes involved in ammonia generation, PDG, glutamate dehydrogenase and PEPCK, and increased expression of the ammonia recycling protein, glutamine synthetase [28 & ,29 & ], responses, opposite that expected from metabolic acidosis. Thus, NBCe1 expression is necessary for normal proximal tubule ammonia metabolism.
In addition to being necessary for normal ammonia metabolism, NBCe1 may also be important for organic anion transport. NBCe1 deletion caused abnormal regulation of expression of the primary proximal tubule citrate transporter, NaDC1 (Fig. 5) [29 & ]. This did not alter net citrate excretion, possibly because of increased activity of a previously described acid-stimulated, calcium-sensitive citrate transport activity [30] . Excretion of another important organic anion, 2-oxoglutarate (also known as a-ketoglutarate), was also altered by NBCe1 deletion. Specifically, NBCe1 deletion dramatically ], as previously described by others [31, 32] . Thus, NBCe1 is necessary for normal proximal tubule bicarbonate reabsorption, and also for two other major roles of the proximal tubule in acidbase homeostasis, namely ammonia generation and organic anion transport/metabolism.
ADVANCES IN AMMONIA TRANSPORT
Collecting duct ammonia secretion involves parallel NH 3 and H þ transport, with little-to-no NH 4 þ permeability [33, 34] . H þ secretion involves H þ -ATPase and H þ -K þ -ATPase. The Rhesus (Rh) glycoproteins, Rhbg and Rhcg, in addition to basolateral Na þ -K þ -ATPase in the inner medullary collecting duct, are involved directly in ammonia transport [4, 35] . Fig. 6 shows a current model of collecting duct ammonia secretion.
Molecular aspects of Rh glycoprotein ammonia transport
The molecular forms of ammonia, NH 3 versus NH 4 þ , that Rh glycoproteins transport, continue to be actively investigated. One important finding from recent studies is the identification that results using the ammonia analogue, methylammonia, may not . Effect of NBCe1 deletion on NaDC1 expression. NaDC1 is an apical Na þ -coupled dicarboxylate (including citrate) transporter present in the proximal tubule that is thought to be the primary mechanism regulating urinary citrate excretion. NBCe1 deletion decreased NaDC1 mRNA (left panels) and immunolabel expression (right panels). The effect was unrelated to the associated metabolic acidosis, as experimental metabolic acidosis in the absence of NBCe1 gene deletion increased NaDC1 mRNA and immunolabel expression. . Model of collecting duct ammonia secretion. Ammonia uptake across the basolateral plasma membrane primarily involves transporter-mediated uptake by either Rhbg or Rhcg, with a component of diffusive NH 3 absorption. Cytosolic NH 3 is transported across the apical plasma membrane by a combination of Rhcg and diffusive transport. Not shown is that in the inner medullary collecting duct, but not the cortical collecting duct, basolateral plasma membrane Na þ -K þ -ATPase also contributes to basolateral NH 4 þ uptake. Cytosolic H þ is generated by a carbonic anhydrase-II mediated mechanism, and is secreted across the apical plasma membrane via H þ -ATPase and H þ -K þ -ATPase. Luminal H þ titrates luminal NH 3 , forming NH 4 þ and maintaining a low luminal NH 3 concentration necessary for NH 3 secretion. Reproduced with permission [35] .
The difference in ammonia species transported by Rhbg and Rhcg is important in their role in collecting duct ammonia secretion. Rhbg is present in collecting duct basolateral plasma membrane, and its electrogenic transport of NH 4 þ results in a greater electrochemical gradient for uptake than would occur for NH 3 transport. Rhcg's transport of NH 3 rather than NH 4 þ is critical for Rhcg to facilitate apical ammonia secretion. Specifically, the low luminal pH and the high pKa' of the NH 3 þ ] in combination with intracellular electronegativity would cause the electrochemical gradient for NH 4 þ movement to be from lumen to cytoplasm, that is, reabsorption, not secretion. Thus, the differential specificities of Rhbg and Rhcg for NH 3 and NH 4 þ contribute to collecting duct ammonia secretion.
CONCLUSION
Ammonia metabolism is critical to acid-base homeostasis for the maintenance of normal health, both under basal conditions and in response to a variety of clinical circumstances. Recent studies have substantially advanced our understanding of ammonia metabolism in a variety of clinically important conditions. Additional studies have advanced understanding of the mechanism of ammonia metabolism by showing critical roles of glutamine synthetase and NBCe1, and by carefully determining the molecular ammonia species transported by Rh glycoproteins.
